Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.37 |
| ▸ | QPCT | Q16769 | 3/20 | 0.36 |
| ▸ | PRKCI | P41743 | 1/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimedazol SCHEMBL28639998 | 1.00 | MAPT (0.45) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Dimedazol SCHEMBL726090 | 0.94 | MAPT (0.41) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Dimedazol SCHEMBL312977 | 0.84 | MAPT (0.56) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Dimedazol SCHEMBL28621495 | 0.82 | MAPT (0.44) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Dimedazol SCHEMBL28640693 | 0.82 | MAPT (0.44) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Dimedazol SCHEMBL61658 | 0.82 | MAPT (0.44) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Dimedazol SCHEMBL727732 | 0.77 | MAPT (0.40) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL12113061 | 0.77 | MAPT (0.61) | MAPTKDM4EALDH1A1APEX1RECQL | |
| SCHEMBL12121772 | 0.77 | MAPT (0.56) | MAPTKDM4EALDH1A1APEX1RECQL | |
| Dimedazol SCHEMBL29097803 | 0.75 | MAPT (0.47) | MAPTKDM4EALDH1A1APEX1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4722287-B2 | — | — | 2011-07-13 | — | — | JP | claimed |
| EP-1228109-B1 | SUPPORTED CATALYST COMPRISING EXPANDED ANIONS | DOW GLOBAL TECHNOLOGIES INC (US) | 2006-02-01 | — | — | EP | claimed |
| US-6716786-B1 | LEWIS ACIDS AND BASES | THE DOW CHEMICAL COMPANY | 2004-04-06 | — | — | US | claimed |
| EP-1056752-B1 | Catalyst activators comprising expanded anions | DOW GLOBAL TECHNOLOGIES INC (US) | 2003-06-25 | — | — | EP | claimed |
| EP-1228109-A1 | SUPPORTED CATALYST COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 2002-08-07 | — | — | EP | claimed |
| US-6395671-B2 | ANION CONTAINING TWO LEWIS BASIC SITES WHICH ARE COORDINATED TO LEWIS ACIDS; FOR OLEFIN POLYMERIZATION | THE DOW CHEMICAL COMPANY | 2002-05-28 | — | — | US | claimed |
| US-6376406-B1 | COORDINATION POLYMERIZATION CATALYSTS FOR ALPHA-OLEFINS | THE DOW CHEMICAL COMPANY | 2002-04-23 | — | — | US | claimed |
| US-20010027161-A1 | Catalyst activators comprising expanded anions | THE DOW CHEMICAL COMPANY | 2001-10-04 | — | — | US | claimed |
| WO-2001023442-A1 | SUPPORTED CATALYST COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 2001-04-05 | — | — | WO | claimed |
| EP-1056752-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 2000-12-06 | — | — | EP | claimed |
| WO-1999042467-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 1999-08-26 | — | — | WO | claimed |
| EP-3519455-B1 | MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4234594-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | Dow Global Technologies LLC (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-2024402-B2 | HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-01-25 | — | — | EP | disclosed |
| US-20220204716-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC | 2022-06-30 | — | — | US | disclosed |
| WO-2001023442-A1 | SUPPORTED CATALYST COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 2001-04-05 | — | — | WO | disclosed |
| EP-1056752-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000020462-A2 | BRIDGED METAL COMPLEXES FOR GAS PHASE POLYMERIZATIONS | BP CHEMICALS LIMITED (GB) | 2000-04-13 | — | — | WO | disclosed |
| WO-2000020426-A1 | BRIDGED METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2000-04-13 | — | — | WO | disclosed |
| WO-1999042467-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 1999-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204716-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | ACSL6, ELOVL6, ALOX5 | MAPT 369/4885KDM4E 2783/4885ALDH1A1 2201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.